Here's the latest on all that, from the able reporting of FiercePharma:
. . .The FDA signed off on the vaccine’s use as an mpox disease preventive in those deemed to be at a high risk for infection.
“This expanded indication for ACAM2000 comes at a critical time as the global health community comes together to ensure an effective and cohesive response to the recent upsurge in mpox cases,” Emergent CEO Joe Papa said in a company press release. “We believe Emergent is poised to support the global response needed by actively engaging with world health leaders, as well as deploying product currently available in inventory based on the needs, as well as the ability to increase supply.”
Until now [Bavarian Nordic's] Jynneos was the only FDA-approved mpox vaccine, leaving Bavarian Nordic racing to fulfill several supply contracts from various governments and public health agencies. That vaccine helped to curb previous mpox outbreaks in 2022 and 2023. The company looks to supply 2 million doses this year and 8 million in 2025 to help to further contain the virus. . . .
Now you know, on a lazy and quiet long weekend here. Grinning, as Tangerine flip-flops, and back again, on women's rights to control their own bodies. It is finally dawning on him that he cannot crack 40% of American women voters unless he flip-flops -- and he loses 95% of the X-ian votes, if he does flip-flop. Private health-care choices -- and bodily autonomy -- are fundamental rights, as Kamala well knows -- and has lived, her whole life. Onward.
नमस्ते
No comments:
Post a Comment